Cetera Investment Advisers
HURA

Cetera Investment Advisers’s TuHURA Biosciences HURA Stock Holding History

Cetera Investment Advisers’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Sell
61,620
-78,624
-56% -$183K ﹤0.01% 4586
2026
Q1 		$251K Buy
+140,244
New +$172K ﹤0.01% 4134

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Cetera Investment Advisers's HURA Position: Q2 2026 in Review

Cetera Investment Advisers reduced its TuHURA Biosciences (HURA) stake by 56% in Q2 2026, selling an estimated $183K and leaving 61,620 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #4586.

Cetera Investment Advisers first reported a position in HURA in Q1 2026 and has held it in 2 quarters since. The position peaked at $251K in Q1 2026. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Cetera Investment Advisers held 61,620 shares of TuHURA Biosciences worth $144K as of Q2 2026.
  • Cetera Investment Advisers sold 78,624 TuHURA Biosciences shares in Q2 2026, an estimated $183K.
  • TuHURA Biosciences made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4586 holding.
  • Cetera Investment Advisers first reported a position in TuHURA Biosciences in Q1 2026 and has held it in 2 quarters since.
  • Cetera Investment Advisers's TuHURA Biosciences position peaked at $251K in Q1 2026.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.